Biosensors represent only a fraction of the rapidly growing sensor and connected device market, yet this area is not one to be overlooked.
This market is expected to grow at a CAGR of 9.12% between 2026 and 2033, reaching an impressive $63.96 billion. A quick look at the current application of biosensors in MedTech, and the advancements and innovations we’ve seen in this field over the past decade, shows why this piece of the industry is worth pursuing.
In this article, we’ll take a closer look at what biosensors are and how they work. We’ll also look at how biosensors are currently being used in healthcare and how you can incorporate technological advancements to ensure your device stands out in this highly innovative market.
What Is a Biosensor?
In simple terms, a biosensor is a sensor that measures a biological element. In more complex terms, it is a sophisticated analytical device that combines a biological recognition element with a transducer to detect and convert a biological response into a measurable signal.
The biological recognition element in these sensor systems can be an enzyme, an antibody, a nucleic acid, or a whole cell. These elements interact with the specific substance or molecule that is to be measured. This interaction triggers a biochemical or biophysical response. The sensor’s transducer element translates this response into a quantifiable signal, such as an electrical, optical, or thermal signal.
In healthcare applications, biosensors play a pivotal role in diagnostics, monitoring, and therapeutics. As key components of the future of healthcare, biosensors promise to revolutionize medical practices, enhance diagnostic precision, and contribute to more effective, personalized patient care.
Types of Biosensors
Several types of biosensors are utilized in the healthcare sector, each tailored to specific medical needs. They can be categorized based on the biological recognition element utilized.
Enzyme-Based
Enzymes are proteins that catalyze specific biochemical reactions. Enzyme-based biosensors rely on the catalytic activity of enzymes to detect and quantify target analytes, such as blood glucose, cholesterol, and certain disease biomarkers.
These biosensors are widely used in various healthcare applications, particularly in diagnostics.
Immunological
Immunological biosensors rely on the specific interaction between antibodies and antigens to detect and quantify target analytes. Common targets include cancer, disease, and autoimmune biomarkers.
These biosensors play a crucial role in diagnostics and disease detection. Some familiar examples include pregnancy tests and rapid tests for COVID and influenza.
DNA-Based
These biosensors leverage the unique properties of DNA, such as its ability to selectively bind with complementary sequences through base pairing, to detect target analytes. These sensors are used in genetic testing, pathogen detection, cancer diagnostics, and environmental monitoring.
DNA-based biosensors are versatile and have applications in diagnostics, monitoring, and genetic analysis.
Optical
Optical biosensors use the interaction between the biological recognition element and the target analyte to induce changes in optical signals, which are then measured and analyzed. This can be accomplished through various means, including surface plasmon resonance (changes in refractive index), fluorescent labeling, and absorbance monitoring.
Like DNA-based sensors, optical biosensors are versatile and have applications in many fields. They are used in diagnostics, environmental monitoring, food safety, and drug testing.
Electrochemical
Electrochemical sensors use electrochemical principles to detect and quantify specific chemicals or analytes. They typically consist of three main components: an electrode, an electrolyte, and a reference electrode. The interaction between the target analyte and the electrode surface generates measurable electrical signals, which are then correlated with the analyte concentration.
These sensors are widely used in various applications, including environmental monitoring, medical diagnostics, and food safety.
This is a conceptual overview of the main biosensor types. For the full picture of what each type can measure, from glucose and lactate to cardiac and hormone markers, see our detailed guide to biosensor capabilities and what they can measure.
Biosensor Applications in MedTech
Biosensors have numerous applications in healthcare. They represent a rapidly evolving area of the MedTech market and have become integral to diagnostics, continuous monitoring, and therapeutics.
Diagnostics
Biosensors play an important role in diagnostics. They are essential to point-of-care testing and a highly useful tool for disease detection.
Point-of-care testing (POCT) refers to medical testing performed near the patient, typically outside of the traditional laboratory setting. Biosensors play a significant role in POCT due to their rapid and on-site diagnostic capabilities. These sensors are often integrated into compact and portable devices, making them suitable for clinics, ambulances, doctors’ offices, and remote testing locations. The rapid results biosensors can provide enable immediate treatment decisions, leading to faster interventions and improved patient outcomes.
Both POCT and other types of biosensors play an important role in disease detection. Enzyme- and DNA-based sensors, in particular, are useful for testing for pathogens, certain types of cancer, and disease-associated biomarkers.
While many biosensors used for this purpose come in expected forms, such as swab-and-read rapid tests, novel biosensors are rewriting the market. One such device is Epicore Biosystems’ discovery patch. This ingenious patch noninvasively collects sweat samples from the user throughout a set period, such as a workout. The sweat can then be easily analyzed to detect certain analytes or discover new biomarkers.
While this device acts more as a collection tool than a sensor, it highlights the potential for creating wearable biosensors that use sweat to collect the biological recognition element needed to diagnose a range of diseases. Epicore Biosystems has already created a device for the consumer market that helps athletes track their hydration levels.
Monitoring and Continuous Healthcare
Biosensors have emerged as transformative components in the realm of wearable and implantable devices, revolutionizing the landscape of monitoring and continuous healthcare.
In wearable applications, biosensors are integrated into devices like smartwatches, fitness trackers, and other wearable gadgets to monitor various physiological parameters continuously. These biosensors often leverage technologies such as optical or electrochemical sensing to enable real-time tracking of vital signs, including heart rate, blood pressure, and glucose levels. This continuous data collection not only provides individuals with immediate insights into their health status but also facilitates the early detection of anomalies or trends, allowing for proactive interventions and personalized healthcare management.
Biosensors also play a crucial role in the development of implantable devices, such as bioelectronic implants or smart prosthetics. Implantable biosensors can monitor specific biomarkers or physiological signals within the body, providing healthcare professionals with valuable information about a patient’s condition. For example, biosensors in implantable devices can be designed to measure glucose levels in people with diabetes or monitor cardiac biomarkers for patients with heart conditions.
One company expanding the possibilities of biosensors for continuous monitoring is Biospectal. Their optical blood pressure monitor can remotely track and record blood pressure readings from the patient’s fingertip. Wearables that utilize noninvasive optical sensors to continuously monitor blood pressure could have a dramatic impact on the 122 million Americans living with hypertension.
Therapeutics
Biosensors are pivotal tools in therapeutics, playing a crucial role in both drug development and personalized medicine.
In drug development and testing, biosensors enable efficient screening of potential drug candidates, offering high sensitivity and specificity in detecting molecular interactions. By using these tools, researchers can assess the binding affinity and pharmacokinetics of drug molecules, accelerating drug discovery and reducing the need for time-consuming and costly assays. Biosensors can also aid in studying cellular responses to drugs, helping to identify potential side effects or adverse reactions early in the development phase.
In personalized medicine, biosensors enable a tailored approach to patient care by providing real-time and individualized information about a patient’s health status. For instance, biosensors can be designed to monitor specific biomarkers relevant to a patient’s condition, allowing healthcare professionals to customize treatment plans based on the patient’s unique biological profile. This precision in diagnostics and treatment leads to more effective, targeted therapies, minimizing adverse effects and optimizing outcomes.
Biosensors are particularly helpful in cancer treatment, providing insight into how drugs affect the patient and tracking disease progression.
Advancements and Innovations for Biosensor Success
Biosensors have long been used in clinical portable devices to diagnose and monitor health conditions. Advancements in technology have opened the door to using these sensors in wearable devices for remote, continuous monitoring of biomarkers, vital signs, and other health markers. As with other aspects of the connected device market, it is essential that developers leverage advancements and innovations in this field to ensure their products meet user expectations.
Miniaturization and Portability
Miniaturization and portability are paramount in the development of biosensors.
Miniaturization enhances the efficiency and versatility of biosensors by reducing the required sample volumes, reaction times, and reagent consumption. Lab-on-a-chip technologies, embodying miniaturization principles, integrate multiple laboratory functions onto a single, compact chip. This advancement facilitates the rapid analysis of complex biological samples with minimal resources, making biosensor applications more accessible in point-of-care settings.
Moreover, the integration of biosensors with smartphones leverages the ubiquitous nature of these devices for real-time data acquisition, processing, and transmission. This synergy enhances access to healthcare diagnostics, particularly in resource-limited settings, by turning smartphones into portable, cost-effective diagnostic tools.
The combination of miniaturization and smartphone integration promises to revolutionize healthcare delivery, enabling faster, decentralized, and personalized diagnostic solutions that transcend traditional laboratory boundaries.
Connectivity and Data Integration
Connectivity and data integration are vital in the development of biosensors in today’s market. Harnessing the power of the Internet of Things (IoT) and cloud-based analytics is necessary to create connected technology capable of analyzing vast amounts of data.
The incorporation of biosensors into the IoT framework allows for seamless communication between these devices and other interconnected systems. This connectivity enables real-time data transmission from biosensors to centralized platforms, fostering continuous monitoring of patient health and environmental parameters.
Cloud-based analytics play a crucial role by providing a robust infrastructure for storing, analyzing, and interpreting the vast amounts of data generated by biosensors. The cloud facilitates remote access to information, allowing healthcare professionals to make informed decisions, track trends, and optimize patient care strategies. Additionally, integrating biosensor data into cloud platforms supports predictive analytics, enabling early detection of health issues and facilitating proactive interventions.
As these devices move from concept toward clinical and commercial use, the software architecture behind them increasingly determines how quickly they reach the market. For a closer look at that dynamic, see our guide to shortening the biosensor regulatory approval process.
Artificial Intelligence and Data Analysis
Artificial intelligence (AI) and advanced data analysis techniques play a pivotal role in the development of biosensors, significantly enhancing their capabilities and impact.
Biosensors generate vast amounts of data. AI provides the means to process and interpret this data with unprecedented speed and accuracy. Machine learning algorithms within AI systems can discern complex patterns, identify trends, and extract valuable insights from the intricate datasets produced by biosensors. AI-driven data analysis enables the identification of subtle biomarker patterns that may indicate disease onset or progression. Additionally, it contributes to the personalization of healthcare by correlating biosensor data with individual patient profiles, facilitating tailored treatment plans.
The integration of AI in biosensor development not only enhances diagnostic precision but also promises predictive analytics, enabling early intervention and preventive measures in healthcare.
Building a Biosensor Device: From Concept to Connected Product
Understanding what a biosensor is and how it works is the starting point. Turning that understanding into a working medical device is a different challenge, one that depends as much on software as on the sensor itself. A biosensor becomes a product only when it is paired with reliable data capture, secure connectivity, a compliant cloud, and the regulatory documentation required for a medical device.
For companies weighing how to develop a biosensor for medical applications, the software foundation is often the deciding factor in how quickly the device reaches the market. Sequenex provides that foundation through its biosensor and CGM software development service, built on the NEX platform under an ISO 13485-certified quality management system, so teams can focus on the sensor and the clinical use case rather than rebuilding the software and compliance layers from scratch.
The Future of Healthcare with Biosensors
Biosensors represent a dynamic and rapidly evolving field with far-reaching implications for the future of healthcare. The versatility of biosensors, ranging from enzyme-based and immunological sensors to DNA-based, optical, and electrochemical sensors, underscores their ability to address diverse healthcare needs.
Devices that utilize biosensors are integral to diagnostics, continuous monitoring, and therapeutics, including the growing field of personalized medicine. To succeed in this rapidly growing and increasingly important market, biosensor device developers need to embrace current trends, including miniaturization, portability, connectivity, and AI integration.
Ongoing advancements in biosensor technologies promise a future where healthcare is not only more accessible but also more proactive and tailored to individual needs, ultimately improving patient outcomes and overall public health.
For companies looking to make their mark in this field, having the right partners will be key to developing a product that is effective and functional enough to meet the needs of patients, doctors, and researchers. Given the importance of connectivity, IoT and AI integration, and a user-friendly smartphone platform, it’s vital to partner with a software company that can deliver the technology to make your innovative biosensor stand out.
Here at Sequenex, we have been helping sensor device companies build better SaMD for years, leveraging our decades of industry experience. We understand the intricacies of today’s biosensor market and the complex regulatory landscape that must be navigated to launch this kind of medical technology. If you have an idea for a connected biosensor device but aren’t sure what the next steps are, we would love to speak with you. Connect with us today to find out how Sequenex can help take your biosensor project to the next level.
